Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhangzhou Pientzehuang Pharmaceutical., Ltd
  6. News
  7. Summary
    600436   CNE000001F21

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

(600436)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Zhangzhou Pientzehuang Pharmaceutical., Ltd Approves Proposal of Investing in Newly Establishing Science and Technology Building

08/21/2020 EST

Zhangzhou Pientzehuang Pharmaceutical. Ltd. approved Proposal of Investing in Newly Establishing Science and Technology Building, at its 6th directorate meeting held on August 20, 2020.


© S&P Capital IQ 2020
All news about ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
10/15Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
07/20MARKET CHATTER : Century-Old Chinese Companies Tap Into Stock Market to Fuel Growth
MT
07/16Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year ..
CI
04/23Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar..
CI
01/27EXCLUSIVE : Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TC..
RE
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
2020China stocks end lower as high-flying consumer shares retreat
RE
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year ..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Approves Proposal of Investing in Newly Est..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd agreed to acquire 29.2% stake in Longhui Ph..
CI
More news
Financials
Sales 2021 7 946 M 1 243 M 1 243 M
Net income 2021 2 523 M 395 M 395 M
Net cash 2021 6 398 M 1 001 M 1 001 M
P/E ratio 2021 105x
Yield 2021 0,28%
Capitalization 265 B 41 406 M 41 403 M
EV / Sales 2021 32,5x
EV / Sales 2022 26,8x
Nbr of Employees 2 526
Free-Float 37,2%
Chart ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Duration : Period :
Zhangzhou Pientzehuang Pharmaceutical., Ltd Technical Analysis Chart | 600436 | CNE000001F21 | MarketScreener
Technical analysis trends ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 438,68 CNY
Average target price 481,83 CNY
Spread / Average Target 9,84%
EPS Revisions
Managers and Directors
Dong Ming Hong Chairman-Supervisory Board
Jie Pan Chairman
Fei Hong Chief Engineer
Jian Jun Jia Independent Director
Guang Pei Li Independent Director
Sector and Competitors